IN185759B - - Google Patents

Info

Publication number
IN185759B
IN185759B IN1927CA1998A IN185759B IN 185759 B IN185759 B IN 185759B IN 1927CA1998 A IN1927CA1998 A IN 1927CA1998A IN 185759 B IN185759 B IN 185759B
Authority
IN
India
Prior art keywords
viral
thrombin
recovery
product
instance
Prior art date
Application number
Other languages
English (en)
Inventor
Bui-Khac Trung
Original Assignee
Corp Haemacure
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corp Haemacure filed Critical Corp Haemacure
Publication of IN185759B publication Critical patent/IN185759B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
IN1927CA1998 1997-10-30 1998-10-29 IN185759B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/960,660 US5981254A (en) 1997-10-30 1997-10-30 Process for producing thrombin from plasma

Publications (1)

Publication Number Publication Date
IN185759B true IN185759B (fr) 2001-04-21

Family

ID=25503448

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1927CA1998 IN185759B (fr) 1997-10-30 1998-10-29

Country Status (16)

Country Link
US (1) US5981254A (fr)
EP (1) EP1027371B1 (fr)
JP (1) JP4278861B2 (fr)
AT (1) ATE305011T1 (fr)
AU (1) AU759145B2 (fr)
CA (1) CA2307380A1 (fr)
DE (1) DE69831684T2 (fr)
DK (1) DK1027371T3 (fr)
ES (1) ES2249843T3 (fr)
IL (1) IL135812A (fr)
IN (1) IN185759B (fr)
NO (1) NO323299B1 (fr)
NZ (1) NZ504246A (fr)
PL (1) PL194589B1 (fr)
RU (1) RU2236237C2 (fr)
WO (1) WO1999023111A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
WO2001045719A1 (fr) * 1999-12-20 2001-06-28 Mitsubishi Pharma Corporation Compositions a base de proteines de plasma exemptes de virus traitees a l'aide d'une membrane poreuse et procede de production
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
CA2395431C (fr) * 1999-12-23 2010-08-17 Csl Limited Purification de fibrinogene present dans des proteases de plasma
JP2002114799A (ja) * 2000-08-01 2002-04-16 Nihon Pharmaceutical Co Ltd ウイルス除去方法
US7411006B2 (en) 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
CA2482856A1 (fr) * 2002-04-15 2003-10-30 American National Red Cross Ligands de liaison a des proteines plasmatiques
US20060275753A1 (en) * 2002-04-15 2006-12-07 Hammond David J Recovery of analytes using combinatorial libraries
US20060275829A1 (en) * 2002-04-15 2006-12-07 Hammond David J Combinatorial library for proteomic investigations
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
DK1528930T3 (da) * 2002-07-23 2009-08-03 Bio & Bio Licensing Sa Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
ES2507091T3 (es) * 2003-12-01 2014-10-14 Novo Nordisk Health Care Ag Nanofiltración de soluciones del factor VII para eliminar virus
CA2570478C (fr) * 2004-06-22 2011-08-23 Zymogenetics, Inc. Compositions de thrombine
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120195953A1 (en) * 2007-09-19 2012-08-02 Kieu Hoang Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
GB0814570D0 (en) * 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
EP2900247B1 (fr) * 2012-09-26 2018-01-17 Bone Therapeutics S.A. Formulations comprenant du plasma traité au solvant/détergent et de l'acide hyaluronique pour le traitement des troubles musculosquelettiques
RU2583931C2 (ru) * 2014-06-11 2016-05-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата тромбина
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
JP6666757B2 (ja) * 2016-03-10 2020-03-18 日本メジフィジックス株式会社 ポリオキシエチレン系非イオン界面活性剤の定量方法及び放射性医薬品製剤の製造方法
AU2019220725A1 (en) * 2018-02-19 2020-07-30 Bayer Healthcare Llc Modified filter membrane and method
WO2020229521A1 (fr) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes pour inhiber ou réduire des biolfilms bactériens sur une surface
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
WO2023020914A1 (fr) 2021-08-18 2023-02-23 Biotest Ag Traitement thermique à sec du facteur viii dérivé du plasma
KR20230121373A (ko) * 2022-02-11 2023-08-18 주식회사 녹십자 인자 xiii의 정제방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography

Also Published As

Publication number Publication date
NO20002293L (no) 2000-06-30
PL194589B1 (pl) 2007-06-29
NO20002293D0 (no) 2000-04-28
ATE305011T1 (de) 2005-10-15
IL135812A0 (en) 2001-05-20
NZ504246A (en) 2002-09-27
RU2236237C2 (ru) 2004-09-20
DE69831684T2 (de) 2006-06-22
US5981254A (en) 1999-11-09
AU759145B2 (en) 2003-04-03
WO1999023111A1 (fr) 1999-05-14
DK1027371T3 (da) 2006-01-09
EP1027371B1 (fr) 2005-09-21
DE69831684D1 (de) 2006-02-02
CA2307380A1 (fr) 1999-05-14
AU9731698A (en) 1999-05-24
PL340300A1 (en) 2001-01-29
ES2249843T3 (es) 2006-04-01
EP1027371A1 (fr) 2000-08-16
JP2001521941A (ja) 2001-11-13
JP4278861B2 (ja) 2009-06-17
NO323299B1 (no) 2007-03-05
IL135812A (en) 2007-09-20

Similar Documents

Publication Publication Date Title
IN185759B (fr)
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
WO1998006483B1 (fr) Technique et appareil correspondant permettant une osmose inverse a haut rendement
MY113939A (en) Method to produce cyclic esters.
EP0125520A3 (fr) Procédé et installation pour la récupération d'un ou de plusieurs constituants d'un mélange gazeux
CA2301371A1 (fr) Procede de blanchiment de pate a papier lignocellulosique
DK0716067T3 (da) Fremgangsmåde til fremstilling af xylitol
YU78402A (sh) Hemostatički aktivni preparat koji sadrži vwf i postupak njegovog pripremanja
JPH05227983A (ja) 米糠蛋白誘導ペプチドの製造方法
EP0221566A3 (en) Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
CA2079238A1 (fr) Procede de separation a membrane
US3619396A (en) Enzymatic production of gluconic acid
DE59713058D1 (de) Verfahren zur herstellung von natriumpercarbonat
DK1071635T3 (da) Fremgangsmåde til rensning af alkalimetalsilicatopløsninger
HUT69604A (en) Process for splitting of proteins
GB9717542D0 (en) Process
NO975005L (no) FremgangsmÕte for fremstilling av en vandig natriumhydroksydl÷sning
AU3823195A (en) Process for recovering citric acid
JPH0272874A (ja) イネモミガラパーオキシターゼの製造方法
FI954109A0 (fi) Menetelmä stabiloidun natriumperkarbonaatin valmistamiseksi
ATE112698T1 (de) Verfahren zur stufenweisen elektrodialyse von alkalisulfathaltigen wässerigen lösungen sowie vorrichtung zur durchführung des verfahrens.
RU93006373A (ru) Способ получения щелочи цезия или рубидия и кислоты
KR870005670A (ko) 디클로로 히드린의 수성 용액 생산의 연속적인 방법
TH18459A (th) กรรมวิธีโอโซน/เพอร์แอซิดซึ่งปรับปรุงให้ดีขึ้นสำหรับการแยกลิกนินออกจากวัสดุลิกโนเซลลูโลส
MX9701265A (es) Procedimiento para tratar una corriente acuosa de desechos de fluoruro de potasio y para convertir este fluoruro de potasio en fluoruro de hidrogeno e hidroxido de potasio.